Shenzhen Hipine Precision Technology Co., Ltd. (HIPINE) announced a voluntary plan to repurchase its H-shares on the Hong Kong Stock Exchange under the general mandate granted at the 11 May 2026 AGM. The mandate allows the company to buy back up to 10% of its issued H-shares (excluding any treasury shares) in the open market.

The aggregate consideration for the repurchase will not exceed the Hong Kong-dollar equivalent of RMB30.00 million, funded exclusively from internal resources such as surplus funds and undistributed profits. In accordance with Rule 10.06(2) of the Hong Kong Listing Rules, the actual repurchase price per H-share may not exceed a 5% premium over the average closing price of the five preceding trading days. Specific repurchase prices will be set by the board based on prevailing market conditions.

The buy-back window extends from the board’s approval date to the earliest of: 1) the conclusion of HIPINE’s next annual general meeting; 2) 12 months after the 11 May 2026 mandate date; or 3) any earlier revocation or variation of the mandate by shareholders.

Repurchased shares will be retained as treasury shares to support long-term incentive plans and strengthen alignment with key personnel. The board stated that existing financial resources are sufficient to fund the programme without impairing the company’s capital position. HIPINE also confirmed compliance with all relevant PRC laws, the Hong Kong Listing Rules, and the Takeovers Code, and does not intend for the repurchase to reduce the public float or trigger a mandatory general offer.

Implementation of the repurchase remains subject to market conditions, share price movements and the company’s capital management considerations. Investors are advised to exercise caution when dealing in HIPINE securities.